Cagrilintide - Dragon Pharma

Buy Cagrilintide Peptide 10 mg by Dragon Pharma at XSteroids. Cagrilintide is a long-acting amylin analogue, the peptide that forms the second half of the CagriSema combination. Dragon Pharma supplies it as a 10 mg lyophilized vial. This guide covers what amylin signalling does, the trial results, cagrilintide dosage practice and how the vial is prepared.

Cagrilintide is an investigational drug without an assigned ATC code, and the information below is educational only.

About Cagrilintide by Dragon Pharma

Cagrilintide is an amylin analogue, which places it in a different family from the GLP-1 drugs. Amylin is a hormone co-secreted with insulin by the pancreas, and it slows gastric emptying and promotes satiety. Pramlintide was the first amylin-based product; cagrilintide is the long-acting version engineered for once-weekly use.

Its development is tied to combination therapy. Novo Nordisk has studied cagrilintide alone and together with semaglutide under the name CagriSema, on the logic that amylin and GLP-1 signalling work through separate receptors and therefore add up.

How Cagrilintide Works

Amylin Receptor Agonism

Cagrilintide activates amylin receptors, which are calcitonin receptor complexes. The effect is slower stomach emptying and increased fullness, so the appetite signal is reinforced through a different pathway than GLP-1. That is why it is described as complementary rather than simply stronger.

Trial Results

In a phase 2 dose-finding trial of once-weekly cagrilintide for weight management, about 31.6% of participants reached at least 15% weight loss, compared with roughly 4.7% on placebo. A separate phase 2 trial co-administered cagrilintide 2.4 mg with semaglutide 2.4 mg in type 2 diabetes, and a 2024 systematic review and meta-analysis of CagriSema found that the combination may provide weight-loss benefits.

Cagrilintide Dosage and Reconstitution

Dosage Practice

Trial protocols use once-weekly administration and escalate gradually, because the gastrointestinal effects are the limiting factor. In research use the dose is measured in micrograms, which means the reconstitution ratio - not the vial size - determines how many units on an insulin syringe match a given amount.

Reconstitution

Mix the lyophilized powder with bacteriostatic water, aiming the stream at the vial wall, then swirl gently instead of shaking. Label the vial with the date, keep the solution refrigerated, and treat a punctured multi-dose vial as usable for 28 days.

How Cagrilintide Compares to Other Incretins

Cagrilintide targets amylin receptors, semaglutide targets GLP-1 only, tirzepatide adds GIP, and retatrutide adds glucagon as well. In research stacks cagrilintide is paired with a GLP-1 to cover both axes, and a cutting phase may also include thermogenics such as Clenbuterol or thyroid support like T3.

Cagrilintide Side Effects and Precautions

Because the mechanism is gastrointestinal, the expected effects are nausea, vomiting, diarrhoea, constipation and reduced appetite, and they are dose-dependent. Amylin analogues also slow stomach emptying, which can matter for anyone taking oral medication. As an unapproved research peptide there is no established long-term safety profile, so blood work, hydration and medical oversight belong in the plan. Persistent severe abdominal pain warrants stopping and seeking medical attention.

Storage Instructions

Store the lyophilized vial in a cool, dry place away from direct light before reconstitution. After mixing with bacteriostatic water, keep the solution refrigerated and use it within the recommended period for peptide solutions. Keep vials out of the reach of children.

Why Buy Cagrilintide from XSteroids?

At XSteroids you buy the Dragon Pharma Cagrilintide vials directly from the brand catalog, with secure checkout, US domestic shipping in 3 to 6 days and international delivery in 12 to 26 days. Browse the full range on the Dragon Pharma brand page to complete your metabolic research stack.